MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
96.14
+0.16
+0.17%
Opening 13:43 02/11 EST
OPEN
96.64
PREV CLOSE
95.98
HIGH
96.64
LOW
93.79
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
124.49
52 WEEK LOW
29.17
MARKET CAP
18.59B
P/E (TTM)
-18.5674
1D
5D
1M
3M
1Y
5Y
1D
Royalty Pharma Q4 adjusted EBITDA beats analyst expectations
Reuters · 8h ago
Noteworthy Monday Option Activity: RVMD, BLSH, MDB
NASDAQ · 2d ago
First-in-Human RMC-5127 Trial Could Be A Game Changer For Revolution Medicines (RVMD)
Simply Wall St · 2d ago
Merck: A Buy For 2026, But The Clock Is Still Ticking
Seeking Alpha · 2d ago
Weekly Report: what happened at RVMD last week (0202-0206)?
Weekly Report · 2d ago
A Look At Revolution Medicines (RVMD) Valuation After First Patient Dosed In RMC-5127 Trial
Simply Wall St · 4d ago
XBI, PCVX, MIRM, RVMD: Large Outflows Detected at ETF
NASDAQ · 5d ago
REVOLUTION MEDICINES INC <RVMD.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $115 FROM $74
Reuters · 6d ago
More
About RVMD
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.